The nucleocapsid (N) protein of mouse hepatitis virus (MHV) and the cellular heterogeneous nuclear ribonucleoprotein A1 (hnRNP-A1) are RNA-binding proteins, binding to the leader RNA and the intergenic sequence of MHV negative-strand template RNAs, respectively. Previous studies have suggested a role for both N and hnRNP-A1 proteins in MHV RNA synthesis. However, it is not known whether the two proteins can interact with each other. Here we employed a series of methods to determine their interactions both in vitro and in vivo. Both N and hnRNP-A1 genes were cloned and expressed in Escherichia coli as glutathione S-transferase (GST) fusion proteins, and their interactions were determined with a GST-binding assay. Results showed that N protein directly and specifically interacted with hnRNP-A1 in vitro. To dissect the protein-binding domain on the N protein, 15 deletion constructs were made by PCR and expressed as GST fusion proteins. Two hnRNP-A1-binding sites were identified on N protein: site A is located at amino acids 1 to 292 and site B at amino acids 392 to 455. In addition, we found that N protein interacted with itself and that the self-interacting domain coincided with site A but not with site B. Using a fluorescence double-staining technique, we showed that N protein colocalized with hnRNP-A1 in the cytoplasm, particularly in the perinuclear region, of MHV-infected cells, where viral RNA replication/transcription occurs. The N protein and hnRNP-A1 were coimmunoprecipitated from the lysates of MHV-infected cells either by an N-or by an hnRNP-A1-specific monoclonal antibody, indicating a physical interaction between N and hnRNP-A1 proteins. Furthermore, using the yeast two-hybrid system, we showed that N protein interacted with hnRNP-A1 in vivo. These results thus establish that MHV N protein interacts with hnRNP-A1 both in vitro and in vivo.
INTRODUCTION
Mouse hepatitis virus (MHV), a prototype of murine coronavirus, is a member of the Coronaviridae family. MHV contains a single-strand, positive-sense RNA genome of 31 kb in length (Pachuk et al., 1989; Lee et al., 1991; Lai and Cavanagh, 1997) . Upon infection, the viral genomic RNA serves as a template for synthesis of a negative-strand, genome-length RNA, which in turn serves as a template for synthesis of six to seven subgenomic mRNAs (Lai and Cavanagh, 1997, and references therein) . Each subgenomic mRNA contains a leader RNA of 72-77 nucleotides in length at the 5Ј-end, which is identical to the genomic RNA leader (Lai et al., , 1984 . Depending on virus strains, there are two to four UCUAA repeats at the 3Ј-end of the leader, with the last repeat being UCUAAAC ). An identical consensus UCUAAAC or similar sequence is present between each gene, termed intergenic (IG) sequence (Budzilowicz et al., 1985; Shieh et al., 1989) , which serves as a joining point between the leader and the body of a subgenomic mRNA. These subgenomic mRNAs are co-nested at the 3Ј-end. Double-stranded replicative-form RNAs and subgenomic negativestranded RNAs complementary to each subgenomic mRNA are also found in infected cells (Sethna et al., 1989; Sawicki and Sawicki, 1990) . It has been suggested that the subgenomic minus-stranded RNAs might be first synthesized from the full-length genomic RNA template during initial transcription and that they subsequently serve as templates for synthesis of subgenomic mRNAs (Sawicki and Sawicki, 1995) .
The precise mechanism(s) of MHV RNA transcription, however, remains elusive. Based on the structural features of the leader-body joining site of each subgenomic mRNA and the sequence complementarity between the 3Ј-end of the leader (5Ј-UCUAAAC-3Ј) and the consensus IG sequence of the negative-strand template (3Ј-AGAUUUG-5Ј), the leader-primed transcription model was proposed to explain how the leader RNA joins to the IG sequence to initiate subgenomic mRNA transcription Spaan et al., 1983; Baric et al., 1985) . A number of subsequent experimental findings are compatible with this model (Lai and Cavanagh, 1997 , and references therein). Using a mutant MHV, JHM2c, however, we previously found that a subgenomic mRNA species (mRNA2-1) can be initiated at a site other than the authentic UAAUAAAC sequence, where there is no sequence complementarity between the leader and the template IG region (Zhang and Lai, 1994) . This kind of mRNA initiation was also observed in a recombinant MHV A59 expressing a green fluorescence protein (Fisher et al., 1997) . To explain how the leader joins to the IG region without sequence complementarity between them, we proposed that both the leader RNA and the IG sequence of the template may first interact with some cellular and/or viral proteins through protein-RNA interactions and that these two RNA elements are then brought together through protein-protein interactions to form a transcription initiation complex (Zhang et al., 1994b; Zhang and Lai, 1994) . Subsequently, using UV cross-linking and gel retardation assays, we and others have identified some cellular proteins that specifically interact with the cis-acting sequences of MHV RNA (Furuya and Lai, 1993; Yu and Leibowitz, 1995; Zhang and Lai, 1995; Li et al., 1997 Li et al., , 1999 .
One of the cellular RNA-binding proteins has been identified as heterogeneous nuclear ribonucleoprotein A1 (hnRNP-A1) (Li et al., 1997) . hnRNP-A1 binds to the negative-strand leader and IG sequences, particularly the consensus (3Ј-AGAUUUG-5Ј) sequence of MHV RNA. Site-directed mutagenesis analysis of the IG consensus sequence further suggests a role of hnRNP-A1 in MHV transcriptional regulation . Although hnRNP-A1 is a nuclear protein, it relocalizes from the nucleus to the cytoplasm during MHV infection; this intracellular relocalization appears to be specific for hnRNP-A1 because another nuclear protein, Sam68, which has been shown to be relocalized to the cytoplasm during poliovirus infection (McBride et al., 1996) , remains in the nucleus of MHV-infected cells (Li et al., 1997) . These findings suggest that there is a physical and possibly functional link between hnRNP-A1 and MHV RNA replication and transcription apparatus (Li et al., 1997; Lai, 1998) . Furthermore, direct evidence for a functional role for hnRNP-A1 in MHV RNA synthesis has been recently demonstrated in MHV-infected cells (Zhang et al., manuscript in preparation) . On the other hand, the nucleocapsid (N) protein of MHV has been shown to bind to the UCUAAAC sequence of the leader RNA Stohlman et al., 1988) . It has thus been suggested that N protein is involved in MHV RNA transcription Stohlman et al., 1988) . The role of N protein in MHV RNA replication has also been demonstrated in an in vitro replication system (Compton et al., 1987) . These findings suggest that both cellular hnRNP-A1 protein and viral N protein are components of the MHV replication and transcription complex. However, it is not known whether they can interact with each other. Since hnRNP-A1 interacts with some serine-arginine (SR)-rich proteins (Cartegni et al., 1996) , and since N protein also contains an SR motif (Peng et al., 1995) , it is conceivable that hnRNP-A1 may interact directly with N protein to bring the leader RNA to the IG sequence of the template RNA for initiation of subgenomic mRNA transcription.
In this study, we thus explored this possibility by directly testing whether hnRNP-A1 directly interacts with MHV N protein in vitro and in vivo. We have expressed both hnRNP-A1 and N genes as glutathione S-transferase (GST)-fusion proteins and determined their interactions by a GST-binding assay. Results showed that hnRNP-A1 directly interacted with N protein in vitro. Using a fluorescence double-staining technique, we found that hnRNP-A1 colocalized with N protein in the perinuclear region of MHV-infected cells. Immunoprecipitation further demonstrated a physical interaction between hnRNP-A1 and N proteins in virus-infected cells. Furthermore, we found that hnRNP-A1 interacted with N protein in a yeast two-hybrid system. These studies thus establish that coronavirus N protein has a protein-binding activity and that it interacts with a cellular component of the putative MHV replication and transcription complex both in vitro and in vivo.
RESULTS

N protein interacts with hnRNP-A1 in vitro
To establish that N protein has protein-binding properties and that it can interact directly with hnRNP-A1, we cloned hnRNP-A1 and MHV N genes into pBluescript vectors for in vitro transcription and translation and into pGEX4-1 vectors for expression of GST fusion proteins. Their interactions were then determined by a GST-binding assay, in which one of the interacting partners is a GST fusion protein that was immobilized on the glutathione-Sepharose beads and the other was radiolabeled with [
35 S]methionine in an in vitro translation reaction. When the GST-N fusion protein and the in vitro translated hnRNP-A1 protein were used in the GST-binding assay, 35 S-labeled hnRNP-A1 was detected (Fig. 1A , lane 1). This interaction was specific for N protein because no 35 S-labeled hnRNP-A1 was pulled down with GST alone (Fig. 1A, lane 2) . The interaction was also specific for hnRNP-A1 because neither 35 S-labeled GFP (green fluorescence protein) nor HE (hemagglutinin/esterase), another MHV structural protein, was brought down by GST-N (Fig. 1A, lanes 3 and 4, respectively) . Interestingly, when the in vitro translation products of hnRNP-A1 and HE were mixed, GST-N protein selectively brought down hnRNP-A1 but not HE (Fig. 1A, lane 5) , indicating that the interaction between GST-N and hnRNP-A1 was specific. Similarly, when the N protein was translated in vitro and hnRNP-A1 was expressed as a GST-fusion protein, N protein specifically bound to the GST-A1 Sepharose beads, but did not bind to GST (Fig. 1B) . These results demonstrate that N protein directly interacts with hnRNP-A1 in vitro.
Next, we employed co-immunoprecipitation as an alternative approach to determine the interaction between hnRNP-A1 and N proteins. GST-N fusion protein was eluted from the glutathione-Sepharose beads, mixed with the 35 S-labeled hnRNP-A1, and immunoprecipitated with an N-specific monoclonal antibody (MAb). The resultant complexes were isolated with protein A-agarose beads and separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). As expected, hnRNP-A1 was detected only when the GST-N fusion protein was present (Fig. 2, lane 5) ; no hnRNP-A1 was coprecipitated by the N-specific MAb when GST alone was used (Fig. 2, lane 6 ), again demonstrating that N protein specifically interacted with hnRNP-A1. The results also showed that the MAb interacted specifically with N protein (Fig. 2 , lane 4) and did not cross-react with hnRNP-A1 protein (Fig. 2, lane 2) .
Because it is known that both hnRNP-A1 and N proteins interact with viral RNAs and some other RNAs, it is possible that hnRNP-A1 might be brought down indirectly through its interaction with RNAs. To investigate this possibility, rabbit reticulocyte lysates were treated with micrococcal nuclease following the in vitro translation reaction. This treatment did not affect the interaction between hnRNP-A1 and N proteins (Fig. 3A) , indicating that hnRNP-A1 directly interacted with N protein. The specificity of this interaction was further demonstrated by a competition assay using bovine serum albumin as a nonspecific competitor (Fig. 3B) . A cold specific competitor (unlabeled hnRNP-A1) could not be used for this experiment due to the formation of oligomers with labeled hnRNP-A1 (data not shown). Oligomerizations among hnRNP-A1 proteins have been reported (Dreyfuss et al., 1993) . To further establish the specificity of this interaction, we used a modified protocol for the competition assay using purified GST-N(III) protein as a specific competitor. GST-N(III) contains the last domain of N protein, which interacts with hnRNP-A1 but which does not interact with itself (N protein) (Fig. 6 ). Various amounts (0-40 g) of purified GST-N(III) protein were mixed with a fixed amount (2 l) of in vitro translated hnRNP-A1 in a protein-binding buffer (the same for GSTbinding assay) and the mixture was incubated at 4°C overnight. Before the GST-binding assay was performed, the GST-binding sites on GST-N-immobilized Sepharose beads were saturated with an excess amount of GST; without this treatment, GST-N(III)-hnRNP-A1 complexes would bind to unsaturated beads in the GST-binding reaction through interactions between GST and glutathione on the beads and not through interactions between hnRNP-A1 and the N moiety of GST-N protein. After saturation, the same amount of GST-N-Sepharose beads were used in a standard GST-binding assay by mixing it with GST-N(III)-35 S-hnRNP-A1. The complexes were then separated by SDS-PAGE. If the interaction between GST-N(III) and 35 S-hnRNP-A1 is specific, with increasing amounts of GST-N(III), decreasing amounts of free 35 S-hnRNP-A1 would be brought down by GST-N-Sepharose beads. As expected, 35 S-hnRNP-A1 was indeed competed by GST-N(III) protein in a concentration-dependent manner. A decrease of 35 S-hnRNP-A1 was readily detectable even when only 10 g of the competitor GST-N(III), an equivalent amount to GST-N, was used in this assay (Fig. 3C, lane 3) . When the amount of GST-N(III) was increased twofold (20 g), hnRNP-A1 was almost completely competed away (Fig.  3C, lane 4) . No hnRNP-A1 could bind to GST-N Sepharose beads when 40 g of the competitor GST-N(III) was used, which is a four times excess over GST-N (Fig. 3C , lane 5). Taken together, these results demonstrate that N protein has protein-binding properties and that it interacts specifically and directly with hnRNP-A1 in vitro.
Characterization of the protein-binding sites on the N protein
Based on a sequence analysis of the N genes of five MHV strains, Parker and Masters (1990) suggested that N protein is composed of three highly conserved structural domains connected to each other by two less conserved spacer sequences. The amino-terminal two domains (domains I and II) are basic and the carboxylterminal domain is acidic. Although the RNA-binding property of N protein has been mapped to be within the middle domain (domain II) (Masters, 1992; Nelson and Stohlman, 1993) , the functions of domains I and III are unknown. Also, the protein-binding property and binding sites on the N protein have not been reported previously.
To dissect the protein-binding site(s) of the N protein, we made a series of deletion constructs by PCR (Fig. 4A) and cloned each into a pGEX4-1 vector for expression as GST-fusion proteins. All proteins were expressed in a substantial amount and the size of each fusion protein corresponded to its expected molecular weight (Fig. 4B ). Although some degradation was observed in a few proteins, the full-length products were still predominant in these proteins (Fig. 4B, lanes 5, 8, 12, and 14) . These truncated GST-N fusion proteins were then used in a GST-binding assay for determining their binding capacity with the in vitro translated, radiolabeled hnRNP-A1. As shown in Fig. 5A , hnRNP-A1 bound to all GST-fusion proteins containing domains I, IIA, and III, but did not bind to the second half of the middle domain [GST-N(IIB), lane 9]. Further deletions of domains I and II of the N protein did not significantly affect the binding with hnRNP-A1 (Fig. 5B ). We thus conclude that N protein contains at least two protein-binding sites: one at the amino terminus from amino acids 1 to 292, and the other at the carboxyl terminus from amino acids 391 to 455 (Fig. 7) . Because all N deletion constructs within the amino-terminal region (domains I and IIA) bound to hnRNP-A1 with similar affinities (Fig. 5B ), we could not determine the exact number of binding sites on this domain (Fig. 7) . The reason for this ambiguity is unknown. One possibility is that the amino-terminal-binding region contains multiple binding sites. Multiple binding sites in a protein are common among chaperone proteins with protein-interacting properties such as hnRNP-A1 (Cartegni et al., 1996) .
Since N protein has protein-binding properties as shown above, an interesting question is whether N protein can interact with itself. If so, what is the exact location of the protein-binding site? To address this question, we used GST-N and its deletion derivatives immobilized on Sepharose beads and the in vitro translated, 35 S-labeled full-length N protein in a GST-binding assay to determine their interactions. As shown in Fig. 6 , the full-length N protein did indeed interact with itself (lane 3). Furthermore, it interacted with domains I and IIA (lanes 3 and 5) but did not bind to domains III and IIB (lanes 4 and 6). We conclude that N protein can interact with itself but that the binding site for N is located in domains I and IIA and not in domains IIB and III. Thus, the protein-binding sites on N protein for binding of N and hnRNP-A1 are different (Fig. 7) .
N protein co-localizes with hnRNP-A1 in the cytoplasm of MHV-infected cells
Although cytoplasmic relocalization of hnRNP-A1 was previously observed in MHV-infected cells, it was not clear what the correlation between cytoplasmic relocalization of hnRNP-A1 and virus replication is, because only a single-labeling immunofluorescence assay was performed (Li et al., 1997) . This question is important because it may relate the biological role of hnRNP-A1 to viral replication and transcription. Also, the above in vitro results suggest that hnRNP-A1 protein may interact with N protein in vivo. We addressed this issue in the present study by employing the double-staining immunofluorescence technique so that the localization of both hnRNP-A1 protein and the N protein (an indicator of virus gene expression) can be monitored simultaneously. Cells were infected with MHV-JHM virus at a multiplicity of infection (m.o.i.) of 1. At various times postinfection (p.i.), cells were stained simultaneously with two primary antibodies (a chicken antiserum specific to hnRNP-A1 and a mouse MAb specific to N protein) and two secondary antibodies (goat anti-chicken IgG conjugated with rhodamine and rabbit anti-mouse IgG conjugated with fluorescein, respectively). Mock-infected cells were used as a control. Results showed that hnRNP-A1 predominantly localized in the nucleus of mock-infected cells or of cells infected with MHV at 0 h p.i. (Fig. 8b ). No N protein was detected in these cells at this time point (Fig. 8a) . At 2 h p.i., cytoplasmic localization of hnRNP-A1 was occasionally observed, whereas the expression of the N protein was still undetectable (data not shown). At 5 h p.i., both N and hnRNP-A1 proteins were detectable and they appeared to colocalize in the cytoplasm under microscopic examination. Confocal laser scanning microscopy further confirmed their cytoplasmic colocalization (data not shown). At 7 h p.i., most cells were fused and syncytia were often observed. Cytoplasmic colocalization of the two proteins was more pronounced at this time point but the cytoplasmic staining generally became weaker, possibly due to diffusion of the dyes . It is noted that the cytoplasmic localization of hnRNP-A1 was not found in all infected cells. In some of the infected cells, determined by the presence of N protein [fluorescein isothiocyanate (FITC)-staining], hnRNP-A1 remained in the nucleus (data not shown). Consistent with this observation is the finding that hnRNP-A1 remained in the nucleus of some cells within a syncytium (Fig. 8e ). In contrast, N protein was detected in the cytoplasm of all cells within the syncytium (Fig. 8d ). The detection of nuclear staining of hnRNP-A1 within the syncytia also suggests that these nuclear-stained cells were not infected primarily but were fused with neighboring infected cells (fusion from within). Importantly, hnRNP-A1 colocalized with N protein in the perinuclear region of the infected cells (Fig. 8f) , where MHV replication and transcription complex also localizes (Denison et Shi et al., 1999) . These results suggest a possible link between hnRNP-A1 and N proteins and MHV replication/transcription apparatus.
Interactions between N protein and hnRNP-A1 in MHV-infected cells
The above finding on colocalization of hnRNP-A1 and N proteins, however, did not indicate a physical interaction between them. To demonstrate a specific interaction between the two proteins in virus-infected cells, we employed an immunoaffinity method. If hnRNP-A1 interacts with the N protein, immunoprecipitation of the cytoplasmic extracts from MHV-infected cells by an antibody specific to one of the two proteins would bring down the other interacting partner. Two opposing approaches were employed. In the first experiment, we used an N-specific MAb to co-immunoprecipitate the N and any other possible interacting proteins in virus-infected cytoplasmic extracts. The immunocomplexes were separated by SDS-polyacrylamide gel electrophoresis and were transferred to nitrocellulose membrane. The presence of hnRNP-A1 was then detected by Western blot analysis with a MAb specific to hnRNP-A1 and a goat anti-mouse IgG antibody conjugated with peroxidase. Consistent with the results from the fluorescence-staining experiment, co-immunoprecipitation of hnRNP-A1 by the N antibody was detectable at 5 h p.i. and became more pronounced at 7 and 9 h p.i. (Fig. 9A) , at which time points viral transcription also reaches a plateau. In the second experiment, we used the hnRNP-A1-specific MAb for immunoprecipitation and the N-specific MAb for Western blot analysis to detect whether N protein could be coprecipitated by the hnRNP-A1-specific MAb. And the results showed that this was indeed the case (Fig.  9B ). These data indicate that N protein interacted directly with hnRNP-A1 in MHV-infected cells.
However, it is also possible that RNAs present in the infected cell lysates might have mediated this interaction as discussed above for in vitro experiments. To investigate this possibility, cytoplasmic extracts were treated with micrococcal nuclease prior to immunoprecipitation. This treatment effectively removed the exogeneously added mRNAs in a control experiment (data not shown) but did not significantly affect the amount of hnRNP-A1 precipitated by the anti-N antibody in Western blot compared to that of the untreated extracts (Fig. 9C) , indicating that viral and cellular mRNAs present in the lysates, if any, did not have a bridging effect on this interaction.
Interactions between N protein and hnRNP-A1 in yeast
Next, we employed the yeast two-hybrid system to further determine whether N protein interacts with hnRNP-A1 in vivo. The yeast two-hybrid system, developed by Fields and Song (1989) , has been widely used as a powerful tool to screen a library for a gene encoding a novel protein that interacts with a known target protein or to test two known, previously cloned proteins for interaction in vivo. We cloned the full-length N gene and hnRNP-A1 gene fused either to the Gal4-DNA-binding domain (DBD) or to the Gal4-transcriptional activation domain (AD) of the vectors pAS2 (plasmid encoding the DBD) and pACT2 (plasmid encoding the AD), respectively. We then co-transformed the pair of plasmid DNAs (pAS2-N and pACT2-A1, or pAS2-A1 and pACT2-N) into the yeast strain Y187. Colonies grown on synthetic dropout (SD) agar plates containing a selection medium [a synthetic minimal medium lacking tryptophan and leucine (SD/-Trp/-Leu)] after incubation for 3 to 5 days at 30°C were tested for the expression of ␤-galactosidase activity by a colony-lift filter assay. As shown in Table 1 , co-transformation of pAS2-N and pACT2-A1 or of pAS2-A1 and pACT2-N resulted in the expression of ␤-galactosidase activity, indicating that the N protein interacted with hnRNP-A1 in yeast. In the control experiments, the same yeast strain, which was co-transformed with two empty vectors, did not express ␤-galactosidase; when the yeast was co-transformed with pLAM5Ј-1 and pTD1-1, which encodes an unrelated protein Gal4-DBD/ human Lamin C hybrid and Gal4-AD/SV40 large T antigen, respectively, no ␤-galactosidase was detected. Yeast transformed with a single vector (either pAS2 or pACT2) did not grow in the selection medium, indicating that there were no nonspecific interactions between proteins expressed from the two vectors. Strong expression of ␤-galactosidase was detected in the yeast co-transformed with pVA3-1 (plasmid encoding Gal4-DBD/murine p53) and pTD1-1, which serves as a positive control. The yeast co-transformed with pAS2-A1 and pACT2-A1 grew in the selection medium and expressed ␤-galactosidase slightly more than that co-transformed with pAS2-A1 and pACT2-N or with pAS2-N and pACT2-A1, but significantly lower than the positive control ( Table 1 ), indicating that hnRNP-A1 self-interaction appeared stronger than that between hnRNP-A1 and N protein. This result is also consistent with a previous report that showed that hnRNP-A1 self-interaction was approximately 30% of the interaction between p53 and SV40 large T antigen in the yeast two-hybrid system (Cartegni et al., 1996) .
DISCUSSION
In the present study, we employed a series of biochemical methods to test the hypothesis that MHV N protein interacts directly with a cellular protein hnRNP-A1, both of which have been implicated in the regulation of MHV RNA replication and transcription (Compton et al., 1987; Stohlman et al., 1988; Zhang and Lai, 1995; Li et al., 1997) . Our results clearly establish that N protein specifically interacts with hnRNP-A1 in vitro, in virus-infected cells, and in yeast. To our knowledge, this is the first report that coronavirus N protein has a protein-binding activity, binding to a cellular protein of the putative transcription and replication complex, in addition to its known RNA-binding activity.
Our results showed that N and hnRNP-A1 proteins colocalized in the cytoplasm of MHV-infected cells, thus extending our previous observation on intracellular redistribution of a single hnRNP-A1 protein (Li et al., 1997) . Significantly, we found that the two proteins co-localized predominantly in the perinuclear region of MHV-infected cells (Fig. 8f) , where active MHV replication/transcription complexes reside (Shi et al., 1999; Denison et al., 1999) . This suggests that both N and hnRNP-A1 proteins are possibly the components of the MHV replication/transcription complex and that their interaction may be involved in regulation of MHV RNA synthesis. The cytoplasmic redistribution of hnRNP-A1 in MHV-infected cells observed in this and a previous study (Li et al., 1997) suggests a physical and, possibly, functional link between hnRNP-A1 and MHV infection. Alternatively, cyto- plasmic relocalization of hnRNP-A1 may be a passive diffusion process due to leakage of the nuclear membrane caused by MHV infection. This is less likely, however, because another nuclear protein, Sam68, which relocalizes from the nucleus to the cytoplasm in poliovirus-infected cells (McBride et al., 1996) , remains in the nucleus of MHV-infected cells (Li et al., 1997) . Also, the observation that hnRNP-A1 remained in the nuclei of many MHV-infected cells, which exhibited positive fluorescence staining of N protein (data not shown), argues that MHV infection does not cause leakage of the nuclear membrane. In no instance we were able to detect cytoplasmic localization of hnRNP-A1 in noninfected cells even though hnRNP-A1 shuttles constantly between the nucleus and the cytoplasm.
The interaction between N and hnRNP-A1 might provide one of the mechanisms by which MHV regulates its discontinuous transcription. We previously proposed that the interaction between the leader and the intergenic sequence of the template RNA, which is a critical step in the initiation of mRNA transcription (based on the leaderprimed transcription model), is mediated through protein-RNA and protein-protein interactions, i.e., cellular and/or viral proteins first bind to the leader and the intergenic sequence of the template RNA through protein-RNA interactions; these two discontiguous RNA sequences are then brought together to form a transcription initiation complex through protein-protein interactions . It has been shown that hnRNP-A1 binds to the intergenic sequence of the negative-strand template RNA and that the N protein binds to the leader RNA Stohlman et al., 1988) . Thus, an attractive possibility is that the interaction between hnRNP-A1 and N proteins would bring the leader RNA to the intergenic sequence of the template to form a ribonucleoprotein complex, which then regulates mRNA transcription. Alternatively, the interaction between N and hnRNP-A1 might also mediate discontinuous transcription during negativestrand synthesis. In that case, N protein would bind to the leader RNA of the genomic RNA template; hnRNP-A1 protein would bind to the intergenic region of the nacent minus-strand RNA transcript. hnRNP-A1 might be already present in the transcription complex or recruited to the intergenic site once the transcription complex moves toward the intergenic region. The presence of hnRNP-A1 at the intergenic site may facilitate an efficient termination (pause) of transcription and resume transcription at the 3Ј-end of the leader through interaction with N and other RNA-binding proteins that are bound to the template leader region. Regardless of which model may be operative, our results are compatible with both models.
Recently, it has been shown that another cellular protein, polypyrimidine tract-binding protein (PTB or hnRNP I), binds to the leader RNA (Li et al., 1999) . Interaction between PTB and hnRNP-A1 has been documented (Dreyfuss et al., 1993) . It is thus conceivable that PTB and N protein may have a synergistic function in bringing the leader to the intergenic sequence for mRNA initiation through interactions with hnRNP-A1 (leader-primed transcription model) or in bringing the template leader to the intergenic site of minus-strand transcripts to resume transcription of the minus-strand subgenomic RNA (discontinuous transcription during minus-strand synthesis). Based on the observation that antibodies specific to N protein inhibited MHV RNA replication in an in vitro replication system, Compton et al. (1987) suggested that an interaction between the N protein and components of the replicase/transcriptase complex might be required for MHV RNA synthesis and that the binding of antibodies to N protein may inhibit such an interaction, thereby inhibiting viral RNA synthesis. Our findings on the interaction between N and hnRNP-A1 protein are consistent with this interpretation. It will be interesting to determine whether N protein also interacts with PTB or other protein components of the replicase complex. Our in vitro data also establish that the N protein interacts with itself (Fig. 6) . Does the N protein also interact with itself in virus-infected cells or in virions? We speculate that it probably does so. Robbins et al. (1986) detected both monomeric and multimeric N proteins in virions and infected cells. This suggests that N-N interactions may be important for encapsidation and virion 
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FIG. 9.
Co-immunoprecipitation of hnRNP-A1 and N proteins from the cytoplasmic extracts of MHV-infected cells by an antibody specific to N or hnRNP-A1. (A) Cells were uninfected (Ϫ) (lane 1) or infected with MHV JHM strain at a multiplicity of infection of 1 (lanes 2 to 6). At 1, 3, 5, 7, and 9 h postinfection (lanes 2 to 6), cytoplasmic lysates were extracted and immunoprecipitated with an N-specific monoclonal antibody and protein A-agarose beads, and the immunocomplex was separated by electrophoresis on SDS-polyacrylamide gel (10%). Proteins were transferred to a nitrocellulose membrane and visualized by Western blot analysis using a monoclonal antibody specific to hnRNP-A1 and a peroxidase-conjugated secondary antibody against mouse IgG. The arrow indicates hnRNP-A1 detected in the Western blot. Molecular mass marker (M) in kilodalton (kDa) shown on the left. (B) Experiments were performed essentially the same as described in (A), except that a monoclonal antibody specific to hnRNP-A1 was used for immunoprecipitation and an N-specific monoclonal antibody for Western blot analysis. The arrow indicates the N protein detected in Western blot. (C) Effects of micrococcal nuclease treatment. Experiments were done in a manner similar to that for (A) lane 6, except that the lysates were treated with (ϩ) (lane 2) or without (Ϫ) (lane 1) micrococcal nuclease (mcn) prior to immunoprecipitation.
assembly. Identification of the interaction between N proteins in this study thus provides biochemical evidence in support of their finding (Robbins et al., 1986) . However, an intriguing question raised from our results is how the N-N protein interactions and the N-viral RNA interactions cooperate if the two different interaction processes are important for encapsidation, since both the protein-interacting (this study) and RNA-binding domains (Masters, 1992; Nelson and Stohlman, 1993) reside in a similar location of the N protein (domain IIA) (Figs. 5, 6, and 7) . Does the protein-protein interaction interfere with the protein-RNA interaction during virus assembly or vice versa? An alternative explanation is that there are multiple protein-binding sites within domains I and IIA of the N protein. This region (approximately 300 amino acids) is large enough to accommodate both protein and RNA molecules at the same time. This is possible since N-N interactions occur independently in domains I and IIA (Fig. 6) . Clearly, the biological role of the protein-protein interaction between N proteins in virus assembly requires further investigation.
MATERIALS AND METHODS
Virus, cells, and antibodies
The MHV JHM(2) strain was used exclusively throughout this study. The murine astrocytoma cell line DBT (Hirano et al., 1974) was used for virus growth, infection, and cell lysate preparation. The mouse MAb J3.3.1 specific to the carboxy-terminal of the MHV N protein (Flemming et al., 1983) and the polyclonal chicken antiserum against an Escherichia coli-expressed murine hnRNP-A1 were kindly provided by Drs. Stephen Stohlman and Michael Lai (University of Southern California, Los Angeles), respectively. The specificity of the latter has been confirmed in Western blot analysis using murine hnRNP-A1 as antigens. A monoclonal antibody specific to the glycine-rich domain of hnRNP-A1 was kindly provided by Dr. Gideon Dreyfuss (University of Pennsylvania).
Plasmid constructions
To express the N protein and its deletion derivatives, a cDNA representing the N gene of MHV JHM strain was cloned into the vector pBluescript (Promega). Total RNAs were isolated from JHM virus-infected DBT cells by the Nonidet-P-40 (NP-40) method as described previously (Zhang et al., 1994b) . cDNAs were synthesized by reverse transcription using the primer 3ЈEcoN and amplified by PCR using a primer pair 5ЈBamN-3ЈEcoN (Table 2) . PCR was performed at 95°C for 30 s, 56°C for 1 min, and 72°C for 2 min in a reaction buffer (20 mM Tris, pH 8.3, 25 mM KCl, 1.5 mM MgCl 2 , 0. 1% Tween 20, a 200 M concentration of each NTP, 20 pmol of each primer) for 25 cycles. The same PCR conditions were used for all plasmid DNA constructions. The PCR fragments were digested with BamHI and EcoRI and directionally cloned into pBluescript vector, generating pBS-N. Sequence of the clone was confirmed using a dye terminator kit (ABI) with the automatic DNA sequencer (Prizm Model 377, ABI) ). pBS-N was then used for PCR amplication using various pairs of primers (see Table 2 and Fig. 4A ). Because all sense primers contain a BamHI site and all antisense primers an EcoRI site, the PCR fragments were digested with BamHI and EcoRI and were directionally cloned into pGEX4-1, resulting in plasmids containing N and various domains of the N protein fused to the carboxyl-terminus of GST (Table  2 and Fig. 6A ). All deletion constructs contain a stop codon at the 3Ј-end to ensure that no additional sequence of the vector would be expressed. For construction of pGST-NI-1, pGST-NI DNA was digested with DraI and EcoRI, bluntended with T4 DNA polymerase, and self-ligated, such that the smaller DraI-EcoRI fragment is deleted.
The previously constructed pBS-mA1 (Zhang et al., 1999) , which contains the full-length murine hnRNP-A1 -TAG GGA TCC ATG TCT TTT GTT CCT-3Ј  30-44  5ЈBamN514  5Ј-TAG GGA TCC GAT ATT GTT GAA-3Ј  514-527  5ЈBamN653  5Ј-TAG GGA TCC CGT GGG CCA A-3Ј  653-666  5ЈBamN775  5Ј-TAG GGA TCC GGC CAG CCT AAG-3Ј  775-788  5ЈBamN904  5Ј-TAG GGA TCC AAT CAG AAT TTT G-3Ј  904-918  5ЈBamN1199  5Ј-TAG GGA TCC CCT AAG CCT CAG A-3Ј  1199-1212  3ЈEcoN183  5Ј-TAG GAA TTC TGC TTG GGC TGA-3Ј  183-170  3ЈEcoN515  5Ј-TAG GAA TTC GGC AGA GGT CCT AG-3Ј  515-502  3ЈEcoN905  5Ј-TAG GAA TTC GGG GCC TCT CTT TC- sequence under the control of T7 promoter in pBluescript vector (Promega), was used for in vitro transcription and translation (see below). pGST-mA1 (Li et al., 1997) was used for expressing hnRNP-A1 as a GST-fusion protein.
For control experiments, the previously constructed p25HE (Liao et al., 1995) and pDE-GFP (Zhang, unpublished results) were used. p25HE and pDE-GFP are DI vectors expressing MHV hemagglutinin/esterase and the green fluorescence protein, respectively. Both DIs were digested with SnaBI and SpeI, blunt-ended with T4 DNA polymerase, and separated by agarose gel electrophoresis. The large fragments were self-ligated such that the HE or GFP ORF is under the control of T7 promoter.
For studying protein-protein interactions in the yeast two-hybrid system (Clontech), the Gal4-DNA-binding domain vector pAS2 was digested with XmaI and bluntended with T4 DNA polymerase. The N and hnRNP-A1 genes were isolated from the plasmids pBS-N and pGSTmA1, respectively, after digestion with BamHI and EcoRI, blunt-ended with T4 DNA polymerase, and cloned into the blunt-ended pAS2 vector, resulting in pAS2-N and pAS2-A1, respectively. The orientation of the inserts was confirmed by restriction enzyme digestions. For construction of the Gal4-AD fusion vector, pACT2 was digested with SfiI, blunt-ended with T4 DNA polymerase, and then digested with EcoRI. For preparing the N and hnRNP-A1 DNA fragments, pBS-N and pGST-mA1 were digested with BamHI, blunt-ended, and then digested with EcoRI. The N and hnRNP-A1 genes were directionally cloned into pACT2 vector, generating pACT2-N and pACT2-A1, respectively.
In vitro transcription
For synthesis of RNAs used for in vitro translation, pBS-mA1 and pBS-N DNAs were linearized with EcoRI and subjected to in vitro transcription. The in vitro transcription was carried out in a standard (50 l) transcription reaction containing 10 mM DTT, 1 U/l RNasin, 0.5 mM each of ATP, CTP, UTP, and cap analog, and 0.05 mM GTP, 5 g pBS-mA1 or pBS-N, 40 U T7 RNA polymerase at 37°C for 1 h according to the procedure recommended by the manufacturer (Promega). To remove the DNA template following the transcription reaction, RQ DNase (Promega) was added to a concentration of 1 unit/g DNA and incubated at 37°C for 15 min. RNAs were purified by passing through a G25 or G50 column (5Ј Primer 3Ј Primer Inc.).
In vitro translation
The in vitro translation reaction was carried out in the rabbit reticulocyte lysate system in the presence of [
35 S]methionine using the in vitro transcribed RNAs according to the manufacturer's recommendations (Promega). For some experiments, the lysate was treated with micrococcal nuclease (20 units/ml) in the presence of 1 mM calcium chloride at 20°C for 10 min following the in vitro translation. The micrococcal nuclease was then inactivated by adding ethylene glycol-bis[b-aminoethyl ether]-N,N,NЈ,NЈ-tetraacetic acid at a final concentration of 2 mM.
Expression of GST-fusion proteins
The procedure for expressing GST-fusion proteins was based on the protocols as described (Smith and Johnson, 1988; Ausubel et al., 1989) . Briefly, pGST-mA1 and pGST-N and its deletion derivatives were transformed into E. coli (DH5␣), and the transformants were grown at 37°C overnight in LB medium in the presence of ampicillin (100 g/ml). Bacterial cultures were diluted with fresh LB medium and incubated for 4 h. At 2 h following the addition of isopropyl-thio-␤-D-galactopyranoside, bacterial cultures were collected by centrifugation, resuspended in phosphate-buffered saline (PBS), and lysed by ultrasonication. Soluble proteins were purified with glutathione-Sepharose beads (Pharmacia). Bound proteins were then eluted by adding free glutathione at 10 mM in Tris buffer (pH 8.0).
Protein-binding assay
GST-binding assays were performed as previously described (Ausubel et al., 1989) . Briefly, 20 l (approximately 10 g) of GST-fusion proteins, coupled to Sepharose beads as described above, was mixed with 5 l of in vitro translated 35 S-labeled A1 protein in 400 l of binding buffer [40 mM (HEPES), pH 7.9, 100 mM KCl, 0.1% NP-40, 20 mM ␤-mercaptoethanol]. After a 4-h incubation at 4°C on a rotating platform, beads were pelleted by centrifugation at 1000 g in microcentrifuge tubes. The beads were then washed four times with 1 ml of the binding buffer. After the final wash, the bead pellets were resuspended in 20 l of 1ϫ Lammeli's sample buffer, boiled for 3 min, and recentrifuged, and the supernatants were analyzed by SDS-PAGE.
Immunofluorescence assay DBT cells were grown on 8-well chamber slides (Lab Tak, Nunc, Nalgene) to subconfluency and infected with JHM virus at an m.o.i. of 1. At different times p.i., cells were fixed with 2% formaldehyde in PBS for 30 min at room temperature and permeabilized with acetone for 10 min at Ϫ20°C. Fixed cells were incubated at 37°C for 1 h in a humidified box following the addition of a mixture of two antibodies (mouse MAb J3.3.1 to N protein and a chicken antiserum to hnRNP-A1). After extensive washing with PBS, cells were stained simultaneously with two secondary antibodies [a rabbit anti-mouse IgG(HϩL)-antibody conjugated with FITC (Sigma) and a goat antichicken IgG(HϩL) antibody conjugated with rhodamine (Sigma)] for 1 h at 37°C. Slides were then washed with PBS and mounted with coverslips. Intracellular localization of hnRNP-A1 and the N protein was observed under the fluorescence microscope (Olympic 1000) with a wavelength of 254 nm for fluorescein and 355 nm for rhodamine. Photographs were taken using the confocal laser scanning microscope at the Core Facility of the Arkansas Cancer Research Center.
Extraction of cytoplasmic proteins
Extraction of cytoplasmic proteins was carried out as described previously (Zhang et al., 1994b) . Briefly, DBT cells were grown on 100-mm petri dishes to confluency and mock-infected or infected with JHM virus at an m.o.i. of 5. At various time points p.i., culture medium was removed. Cells were washed with ice-cold PBS twice, scraped with a rubber policeman into microcentrifuge tubes, and pelleted by centrifugation for 20 s. Cell pellets were resuspended in 300 l of an extraction buffer [10 mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM ethylenediaminetetraacetic acid, 1 mM dithiothreitol (DTT), 0.5 mM phenylmethylsulfonyl fluoride (PMSF)] by gentle pipetting and incubated on ice for 15 min. Following the addition of 25 l of 10% NP-40, the cell suspension was mixed vigorously by vortexing for 20 s and centrifuged at 4°C for 2 min in a microcentrifuge. Pellets, which contain the nuclei, were discarded, and supernatants, which represent the cytoplasmic fraction, were collected. The protein concentration of the cytoplasmic extracts was determined with a Bio-Rad protein assay kit (Bio-Rad).
Immunoprecipitation
Immunoprecipitation was carried out in 500 l of RIPA buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 0.5% NP-40, 0.1% SDS, 1 mM PMSF) containing various amounts of infected and noninfected cytoplasmic extracts and the N-specific MAb J3.3.1 by constant rocking on a rocking platform at 4°C overnight. The antibody-antigen complexes were then precipitated with protein A-agarose beads at 4°C for 2-4 h. Agarose beads were washed three times with RIPA buffer. Proteins complexes were denatured by boiling for 3 min in Lammeli's sample loading buffer (100 mM Tris, pH 6.8, 200 mM DTT, 4% SDS, 0.2% bromophenol blue, 20% glycerol) and analyzed by PAGE. Proteins were then detected by Western blot analysis. For detection of in vitro protein-protein interactions, the GST-fusion proteins and the in vitro-translated proteins were mixed in RIPA buffer followed by the addition of N-specific MAb J3.3.1. Immunoprecipitates were analyzed by SDS-PAGE and the gels were exposed to X-ray film and autoradiographed.
Western blot
Western blot was performed as described previously (Zhang et al., 1994a) with slight modifications. Briefly, following SDS-PAGE, proteins were transferred onto nitrocellulose membranes (Amersham) using a Bio-Rad Mini Transfer Blot at 60 V overnight at 4°C. Membranes were dried and blocked with either 10% skim milk or 2% bovine serum albumin in PBS for 2 h at 37°C. The membranes were incubated with the primary antibody (MAb specific to hnRNP-A1, 1:500 dilution) for 2 h at 37°C. After extensive washing, the membranes were incubated with a goat anti-mouse IgG secondary antibody conjugated with horseradish peroxidase (1:10,000 dilution) (Sigma) for 2 h. The substrate, diaminobenzidine (0.075%), and hydrogen peroxide (0.003%) were used to visualize the protein bands.
The yeast two-hybrid system
The Matchmaker Two-Hybrid System 2 (Clontech, Palo Alto, CA) was used for testing the interaction between the N protein and hnRNP-A1 in vivo. All procedures for growing yeast, transformation, selection, and ␤-galactosidase colony-lift filter assay essentially followed the protocol provided by the manufacturer (Clontech).
